NasdaqGM - Delayed Quote USD
NewAmsterdam Pharma Company N.V. (NAMS)
At close: November 6 at 4:00 PM EST
After hours: November 6 at 4:01 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AUDET JULIETTE BERANGERE Officer | Purchase | Sep 26, 2024 | 1,104 |
| BALTERA ROBERT F JR. Director | Conversion of Exercise of derivative security | Nov 22, 2022 | 0 |
| BIGHAM MICHAEL F Director | Conversion of Exercise of derivative security | Nov 22, 2022 | 0 |
| DAVIDSON MICHAEL H Chief Executive Officer | Purchase | Aug 20, 2024 | 818,563 |
| KASTELEIN JOHANNES JACOB PIETER M.D., PH.D. Officer and Director | Conversion of Exercise of derivative security | Mar 26, 2024 | -- |
| KOOIJ LOUISE FREDERIKA Officer | Sale | Oct 1, 2024 | 0 |
| LANGE LOUIS G M.D., PH.D. Director | Purchase | Feb 13, 2024 | -- |
| POLU KRISHNA R Director | Conversion of Exercise of derivative security | Nov 22, 2022 | 0 |
| TOPPER DAVID JOSEPH Chief Financial Officer | Conversion of Exercise of derivative security | Nov 22, 2022 | 0 |
| TOPPER JAMES N Director | Purchase | Mar 26, 2024 | -- |
Related Tickers
SYRE Spyre Therapeutics, Inc.
37.48
+4.34%
MRUS Merus N.V.
53.13
+2.67%
CGEM Cullinan Therapeutics, Inc.
16.48
+3.13%
ATXS Astria Therapeutics, Inc.
11.87
+3.13%
TYRA Tyra Biosciences, Inc.
17.12
+2.15%
BCYC Bicycle Therapeutics plc
23.64
+0.55%
DYN Dyne Therapeutics, Inc.
29.81
+4.16%
XENE Xenon Pharmaceuticals Inc.
44.94
+3.72%
IRON Disc Medicine, Inc.
64.80
+0.04%
NMRA Neumora Therapeutics, Inc.
12.71
+6.72%